The CMO/CDMO biotechnology market refers to the global market for contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) that provide biotechnology manufacturing and development services to pharmaceutical and biotech companies. These organizations offer a range of services, including process development, scale-up, and manufacturing of biologics, cell therapies, and gene therapies. The market for CMO/CDMO biotechnology is driven by the increasing demand for outsourcing biotech manufacturing and development services, as well as the growing prevalence of chronic diseases that require advanced biologic therapies.
Global revenue from the CMO/CDMO biotechnology market stands at US$ 10.2 Bn in 2022, with the worldwide market estimated to surge ahead at a CAGR growth value of 11.6% to reach a valuation of around US$ 34.1 Bn by the end of 2033.
Need More Insights on Competitor Analysis of the CMO/CDMO Biotechnology Market, Request a Samples copy
One of the key drivers of the CMO/CDMO biotechnology market is the increasing complexity of biological drugs and therapies. Biologics are large, complex molecules that require specialized manufacturing processes and facilities. Many pharmaceutical and biotech companies lack the resources and expertise needed to manufacture these therapies in-house, leading to a growing demand for CMO/CDMO biotechnology services.
Companies
- Patheon N.V.
- Catalent
- Samsung Biologics Co., Ltd
- Boehringer Ingelheim
- Samsung BioLogics
- AGC Biologics, Inc.
- WuXi Biologics
- AbbVie Inc
- Avid Bioservices, Inc.
- Fujifilm Diosynth Biotechnologies
- Xpress Biologic
- Rentschler Biopharma SE
- KBI Biopharma (JSR Corporation)
- Cytovance Biologics
If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/32516
However, there are also some challenges that the CMO/CDMO biotechnology market faces. One of the main challenges is the high cost of biotech manufacturing and development services, which can limit their adoption, particularly for smaller biotech companies with limited resources. Additionally, there is a need for further investment in infrastructure and regulatory oversight to ensure the safety and quality of biological therapies.
Overall, the CMO/CDMO biotechnology market is expected to continue to grow in the coming years, driven by ongoing advancements in biotechnology and the increasing demand for outsourcing biotech manufacturing and development services. With increasing investment in research and development, and the development of new technologies, the CMO/CDMO biotechnology market is likely to play a significant role in the future of healthcare.
Competitive Landscape
Key players are concentrating on expansion in emerging regions and new revised product manufacturing. Market participants are also working to strengthen their expansion, new product launches, and improved distribution channels such as online sources of advertisement.
For instance:
For instance, Iovance Biotherapeutics chose Avid Bioservices in August 2020 to spearhead process development through cGMP manufacture of IOV-3001, an innovative anti-cancer medication candidate and new IL-2 analog.
Fujifilm Diosynth Biotechnologies in April 2021, announced the establishment of its new Microbial production facility in the U.K. This expansion aimed to triple the existing microbial production. This new production facility was equipped with 2*2000L of fermenters and modular purification suits.
If you want to Purchase Specific Insights by Segment/Region/Competitor, Request For Customization @ https://www.persistencemarketresearch.com/request-customization/32516
Key Segments Covered in CMO/CDMO Biotechnology Industry Research
By Service:
- Stand-Alone Services
- Cell-line development
- Development and Biomanufacturing
- Analytical Services
- Fill Finish
- Packaging
- Clinical Supply Services
- Integrated
By Product:
- Monoclonal Antibodies
- Antibody Fragments
- Recombinant Therapeutic Proteins
- Viral Vector
- Cell and Gene Therapy
- Vaccine
By Expression System:
- Mammalian
- Microbial
- Bacteria
- Yeast
By Company Size:
- Small
- Mid-Sized
- Large
- Very Large
By Scale of Operations:
- Pre-clinical
- Clinical
- Commercial
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, semiconductors and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
